Cancer

Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.

Pancreatic cancer is deadly, and its toll is growing. Scientists find that scar tissue around the tumor suggests how long a patient will live after diagnosis.

To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.

National guidelines for lung cancer screening are less effective for African Americans than for whites, Stanford study concludes. A risk-based analysis is more equitable and effective.

Small cell lung cancers often metastasize to the brain. A Stanford Medicine study shows they thrive there by emulating developing neurons and recruiting surrounding cells for protection.

The award will facilitate a clinical trial testing the safety of CAR-T cells — immune cells from patients’ own bodies that have been bioengineered to destroy cancer cells — used to treat a deadly brain cancer.

Two professors are named Innovation Investigators, and four win Ignite Awards.

Physicians, researchers and other pacesetters describe some of the most promising pursuits in the medical field. In cancer, for instance: ‘Let’s kill the first cell, not the last cell.’…

New technology combines radiotherapy with real-time detection of cancer cells to target moving tumors or multiple metastases. Stanford Medicine is the first to research the technology in the clinic.

Stanford Medicine scientists and colleagues create an algorithm that could help physicians better understand and target complicated brain tumors.

The tumor suppressor p53 has been in the limelight for decades. But its cancer-fighting function may be only a side effect of its role in tissue repair, a Stanford Medicine study finds.